Fig. 1From: Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case reportEvolution of periampullary adenopathies on reintroduction of regorafenib. A In january 2017 periampullary adenopathies were seen on follow-up CT-scan. B CT-scan after 6 months of treatment with regorafenib shows a partial responseBack to article page